RPTX (Repare Therapeutics) OCF Margin %: 22.81% (As of Sep. 2025)


RPTX Repare Therapeutics Inc RPTX
20 GF Score
Price $2.65
GF Value $0.94
! 6 Warning Signs
View Full Analysis

What is Repare Therapeutics OCF Margin %?

Repare Therapeutics RPTX 20 OCF Margin % is 22.81% as of Sep. 2025. GuruFocus rates RPTX with a GF Score™ of 20/100 and a GF Value™ of $0.94. The stock has 6 warning signs investors should review.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Repare Therapeutics's Cash Flow from Operations for the three months ended in Sep. 2025 was $2.65 Mil. Repare Therapeutics's Revenue for the three months ended in Sep. 2025 was $11.62 Mil. Therefore, Repare Therapeutics's OCF Margin % for the quarter that ended in Sep. 2025 was 22.81%.

As of today, Repare Therapeutics's current OCF Yield % is -61.41%.

The historical rank and industry rank for Repare Therapeutics's OCF Margin % or its related term are showing as below:

RPTX' s OCF Margin % Range Over the Past 10 Years
Min: -4506.67   Med: -248.68   Max: 0.24
Current: -590.97

During the past 8 years, the highest OCF Margin % of Repare Therapeutics was 0.24%. The lowest was -4506.67%. And the median was -248.68%.

RPTX's OCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -66.52 vs RPTX: -590.97

Repare Therapeutics OCF Margin % Related Terms

Repare Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Repare Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Repare Therapeutics OCF Margin % Chart

Repare Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial -4,506.67 -1,128.89 0.24 -248.68 -142.95

Repare Therapeutics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -6,536.80 22.81

RPTX vs MGNX, THAR, ANIX: OCF Margin % Comparison

For the Biotechnology subindustry, Repare Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Repare Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Repare Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Repare Therapeutics's OCF Margin % falls into.


RPTX
20GF Score
Repare Therapeutics Inc RPTX
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Repare Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Repare Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-76.445/53.477
=-142.95 %

Repare Therapeutics's OCF Margin for the quarter that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=2.651/11.62
=22.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 22.81% mean?
Repare Therapeutics (RPTX) has a OCF Margin % of 22.81% as of Sep. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Repare Therapeutics and its competitors.
Is Repare Therapeutics' OCF Margin % too high?
Repare Therapeutics' current OCF Margin % is 22.81%. Overall, Repare Therapeutics has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Repare Therapeutics' OCF Margin % compare to MGNX and THAR?
Repare Therapeutics' OCF Margin % of 22.81% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Repare Therapeutics and its competitors. Repare Therapeutics's current OCF Margin % is 22.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Repare Therapeutics stock overvalued right now?
Repare Therapeutics (RPTX) has a current OCF Margin % of 22.81%. The stock's GF Value™ is $0.94, compared to a current price of $2.65 — trading 181.9% above its estimated fair value. The current OCF Margin % is 22.81%. Repare Therapeutics' overall GF Score™ is 20/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Repare Therapeutics (RPTX), the current OCF Margin % is 22.81% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Repare Therapeutics (RPTX) Overvalued in 2026?

Based on GuruFocus' analysis, Repare Therapeutics stock appears to be overvalued. The current stock price of $2.65 is trading 181.9% above its estimated GF Value™ of $0.94.

Key valuation signals for RPTX:

  • OCF Margin %: 22.81%
  • GF Value™: $0.94 vs. price of $2.65 (181.9% above fair value)
  • GF Score™: 20/100 with 6 warning signs

No single metric tells the full story. See the RPTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Repare Therapeutics Business Description

Address 7210 Frederick-Banting Street, Suite 100, Saint-Laurent, QC, CAN, H4S 2A1
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
20GF Score

Get the complete analysis for RPTX

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.65
Price
$0.94
GF Value